REVELATION BIOSCIENCES, INC.
REVELATION BIOSCIENCES, INC. (REVB): 5 pipeline candidates · ~13 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
13.2 months
D/E 0.16 · 0% dilution
Lead: Phase 2
5 candidates
N/A
N/A
A transparent, data-derived signal for REVELATION BIOSCIENCES, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$3.8M
Cash
$14.1M
Quarterly Burn
$3.2M
Runway
13.2 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (5 candidates)
| Drug | Phase |
|---|---|
| gemini | Phase 2 |
| gemini-aki | Phase 1 |
| gemini-ckd | Phase 1 |
| gemini-psi | Preclinical |
| intravenous gemini | Phase 1/Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$589K
| Holder | Shares | Value |
|---|---|---|
| armistice capital, llc | 323,241 | $388K |
| sabby management, llc | 99,432 | $119K |
| geode capital management, llc | 43,195 | $52K |
| vanguard fiduciary trust co | 13,127 | $16K |
| xtx topco ltd | 11,385 | $14K |
| royal bank of canada | 747 | $1K |
| bnp paribas asset management holding s.a. | 9 | $11 |
| caitong international asset management co., ltd | 1 | $1 |
Frequently asked questions
How many drug candidates are in REVELATION BIOSCIENCES, INC.'s pipeline?
REVELATION BIOSCIENCES, INC. (REVB) has 5 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is REVELATION BIOSCIENCES, INC.'s lead drug candidate?
REVELATION BIOSCIENCES, INC.'s most advanced tracked candidate is gemini (Phase 2) for Renal Insufficiency, Chronic.
What is REVELATION BIOSCIENCES, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, REVELATION BIOSCIENCES, INC. has approximately 13.2 months of cash runway.
What is REVELATION BIOSCIENCES, INC.'s market capitalization?
REVELATION BIOSCIENCES, INC.'s market capitalization is approximately $3.8M.
Who is the CEO of REVELATION BIOSCIENCES, INC.?
Mr. James M. Rolke is the chief executive officer of REVELATION BIOSCIENCES, INC. (REVB).
Get the full picture on REVELATION BIOSCIENCES, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.